Future Science GroupBrowse
Supplementary Tables 1-5.docx (132.45 kB)
Download file

Supplementary Tables 1-5. Burden of Illness & Outcomes in 2nd Line Large B-Cell Lymphoma Treatment: Real-world Analysis of Medicare Beneficiaries

Download (132.45 kB)
dataset
posted on 2021-10-20, 08:18 authored by Karl M. Kilgore, Iman Mohammadi, Anny C. Wong, Julia Thornton Snider, Paul Cheng, Amy Schroeder, Anik R. Patel
Supplementary Tables 1-5. Burden of Illness & Outcomes in 2nd Line Large B-Cell Lymphoma Treatment: Real-world Analysis of Medicare Beneficiaries

Table 1. Standard First and Second LOT Regimens1
Table 2. Qualifying Stem-cell Treatment Codes
Table 3. LBCL-Related HRU
Table 4. LBCL-Related Costs PPPM
Table 5. Adverse Event Code Sets

Funding

Kite, A Gilead Company, Santa Monica, CA

History

Usage metrics

Read the peer-reviewed publication

Burden of Illness & Outcomes in 2nd Line Large B-Cell Lymphoma Treatment: Real-world Analysis of Medicare Beneficiaries
Future OncologyFuture Oncology

Categories

Keywords

Economic burdenMedicarelarge B-cell lymphomaline of therapystem-cell transplanttreatment patternsCancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0

Exports